Seeking Alpha

Shares of microcap Orexigen Therapeutics (OREX) are up 73% premarket after the firm announces a...

Shares of microcap Orexigen Therapeutics (OREX) are up 73% premarket after the firm announces a meeting with the FDA led to a "clear and feasible" path for its Contrave drug to meet approval to treat obesity.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector